YAK-1 related serine/threonine protein kinase-HTLAR33
AssigneeSmithKline Beecham Corporation
InventorsDerk Bergsma, Usman Shabon
Life of this patent
Estimating the term…
Abstract
HTLAR33 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also, disclosed are methods for utilizing HTLAR33 polypeptides and polynucleotides in therapy, and diagnostic assays for such.
Claims6
An isolated polypeptide having at least 70% identity to the amino acid sequence of SEQ ID NO:2 over the entire length of SEQ ID NO:2, wherein said polypeptide has serine/threonine kinase activity.
An isolated polypeptide having at least 80% identity to the amino acid sequence of SEQ ID NO:2 over the entire length of SEQ ID NO:2, wherein said polypeptide has serine/threonine kinase activity.
An isolated polypeptide having at least 90% identity to the amino acid sequence of SEQ ID NO:2 over the entire length of SEQ ID NO:2, wherein said polypeptide has serine/threonine kinase activity.
An isolated polypeptide having at least 95% identity to the amino acid sequence of SEQ ID NO:2 over the entire length of SEQ ID NO:2, wherein said polypeptide has serine/threonine kinase activity.
An isolated polypeptide comprising the amino acid sequence of SEQ ID NO:2.
An isolated polypeptide consisting of the amino acid sequence of SEQ ID NO:2.
Dependencies are inferred from the claim text.